However today I believe “We have come a long way baby!” The IMF conducted a symposium on Friday titled “TREATMENT ADVANCES IN MULTIPLE MYELOMA: EXPERT PERSPECTIVES ON TRANSLATING CLINICAL DATA TO PRACTICE.”
The expert panel included Dr. Rajkumar, and Dr. Shaji Kumar from Mayo Clinic, Dr. Philippe Moreau of France, Dr. Jesus San-Miguel (seem to be the character of the bunch), and Dr. Bruno Pavia, both of Spain. The program was moderated by the president of the IMF Dr. Brian Durie.
Case studies were presented and the panel and audience would vote on a number of ways to treat the case. What became obvious was that the panel consistently gave the same answers, whereas the audience answers were not nearly consistent.
This could lead me to only one conclusion: the myeloma specialist are finally obtaining a consensus opinion on treatment but the general hematologist/oncologist (audience) has not yet reached the same level of congruence. So one of the most significant takeaways from the three hour symposium was the templates which were presented for both newly diagnosed and relapsed/refractory myeloma. This template is much like a Cliff Notes version of mSmart the Mayo Clinic template for treatment. You will note the newly diagnosed and relaspe slides below.
Dana Holmes has recently provided her logic in a facebook post. Because it is so well written, I will post it seperately. She is writing it to her smoldering myeloma facebook group, but I would argue it is even far more critical if you have active myeloma, or are in your second or greater relapse.
Good luck and may God Bless your Cancer Journey. For more information on multiple myeloma survival rates and treatments CLICK HERE and you can follow me on twitter at: https://twitter.com/grpetersen1